You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR G724X

Showing 1 - 25 of 2,667
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

Not yet recruiting
  • EGF-R Positive Non-Small Cell Lung Cancer
  • +4 more
  • Stereotactic Body Radiation Therapy SBRT
  • Bogotá, Colombia
    CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
Aug 16, 2023

NSCLC, EGFR G719X, EGFR L861Q Trial in Chongqing (Furmonertinib 160 mg, Q.D.)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Furmonertinib 160 mg, Q.D.
  • Chongqing, Chongqing, China
  • +2 more
Sep 16, 2022

PFS Trial in Qingdao (afatinib)

Recruiting
  • PFS
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

Lung Cancer Trial in Worldwide (T790M+ Testing, Baseline Visit Blood & Urine Testing, Baseline ECG)

Completed
Has Results
  • Lung Cancer
  • T790M+ Testing
  • +4 more
  • Buenos Aires, Argentina
  • +200 more
Nov 10, 2021

NSCLC Trial (Furmonertinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Aug 10, 2023

Agitation in Patients With Dementia of the Alzheimer's Type Trial in Worldwide (AVP-786, Placebo)

Recruiting
  • Agitation in Patients With Dementia of the Alzheimer's Type
  • Phoenix, Arizona
  • +73 more
Jul 22, 2022

Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • (no location specified)
Sep 15, 2023

NSCLC Trial in Singapore (Afatinib 40 MG)

Not yet recruiting
  • NSCLC
  • Afatinib 40 MG
  • Singapore, Singapore
    National University Hospital
Sep 25, 2023

A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +4 more
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Oct 25, 2022

    Non-squamous NSCLC Trial (biological, drug, dietary supplement)

    Not yet recruiting
    • Non-squamous NSCLC
    • Pembrolizumab
    • +7 more
    • (no location specified)
    Feb 20, 2023

    EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

    Active, not recruiting
    • EGFR-mutant Non-small Cell Lung Cancer
    • Toronto, Ontario, Canada
    • +10 more
    Dec 5, 2022

    NSCLC Trial in Guangzhou (Neratinib tablets)

    Not yet recruiting
    • NSCLC
    • Neratinib tablets
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 1, 2023

    Treatment, Treatment Side Effects Trial in China (YK-029A)

    Recruiting
    • Treatment
    • Treatment Side Effects
    • Hefei, Anhui, China
    • +34 more
    Mar 15, 2023

    NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +14 more
    • Glendale, California
    • +12 more
    Feb 2, 2023

    EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC

    Recruiting
    • Non-small Cell Lung Cancer
      • Changsha, Hunan, China
        Yongchang Zhang
      Feb 28, 2022

      NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Carboplatin)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Los Angeles, California
      • +83 more
      Jan 31, 2023

      NSCLC Trial in Worldwide (Durvalumab, Placebo, Osimertinib (single-arm, open-label))

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Tuscaloosa, Alabama
      • +260 more
      Dec 16, 2022

      Lung Cancer Trial in Worldwide (Erlotinib, Bevacizumab)

      Completed
      Has Results
      • Lung Cancer
      • Caen, France
      • +47 more
      Aug 23, 2022

      Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)

      Recruiting
      • Heart Failure
      • Chronic Kidney Disease
      • Hot Springs National Park, Arkansas
      • +279 more
      Feb 1, 2023

      Advanced Lung Adenocarcinoma Trial (TCM Formula, Placebo)

      Completed
      • Advanced Lung Adenocarcinoma
      • TCM Formula
      • Placebo
      • (no location specified)
      Jan 9, 2022

      Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)

      Active, not recruiting
      • Non Small Cell Lung Cancer Metastatic
      • Dublin, Ireland
      • +24 more
      Aug 23, 2022

      NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Kunming (Combined therapy of anlotinib and aumolertinib)

      Recruiting
      • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
      • Combined therapy of anlotinib and aumolertinib
      • Kunming, Yunnan, China
        First Affiliated Hospital of Kunming University
      Oct 22, 2023

      Non Small Cell Lung Cancer Trial in Durham, Columbus, Pittsburgh (osimertinib)

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • Durham, North Carolina
      • +2 more
      Jun 30, 2022